SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from NxStage Medical, Inc. (CIK 0001333170) — Oct 21, 2005

NxStage Medical, Inc. (CIK 0001333170)
Date: Oct. 21, 2005 · CIK: 0001333170 · Accession: 0000950135-05-005893

AI Filing Summary & Sentiment

Date
October 21, 2005
Author
Not clearly detected
Form
CORRESP
Company
NxStage Medical, Inc. (CIK 0001333170)

Letter

Via EDGAR and Facsimile Securities and Exchange Commission Re: NxStage Medical, Inc. Registration Statement on Form S-1 (File No. 333- 126711) Request for Acceleration

Dear Mr. Mancuso:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, NxStage Medical, Inc., a Delaware corporation (the “Registrant”), hereby requests that the above-referenced Registration Statement be made effective as of 3:30 p.m., Eastern time, on October 25, 2005, or as soon thereafter as practicable.

The Registrant hereby acknowledges that:

(i)

should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

(ii)

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

(iii)

the Registrant may not assert the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

[Remainder of page intentionally left blank; signature appears on next page.]

Very truly yours,
NxSTAGE MEDICAL, INC.

Show Raw Text
CORRESP
1
filename1.htm

corresp

NxSTAGE MEDICAL, INC.

439 South Union Street

5th Floor

Lawrence, MA 01843

          October 21, 2005

Via EDGAR and Facsimile

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Attn: Russell Mancuso, Esq.

    Re:

    NxStage Medical, Inc.

    Registration Statement on Form S-1 (File No. 333- 126711)

    Request for Acceleration

Dear Mr. Mancuso:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, NxStage Medical, Inc., a
Delaware corporation (the “Registrant”), hereby requests that the above-referenced Registration
Statement be made effective as of 3:30 p.m., Eastern time, on October 25, 2005, or as soon
thereafter as practicable.

The Registrant hereby acknowledges that:

    (i)

    should the Securities and Exchange Commission (the “Commission”) or the staff,
acting pursuant to delegated authority, declare the Registration Statement effective,
it does not foreclose the Commission from taking any action with respect to the
Registration Statement;

    (ii)

    the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the Registration Statement effective, does not relieve the
Registrant from its full responsibility for the adequacy and accuracy of the disclosure
in the Registration Statement; and

    (iii)

    the Registrant may not assert the action of the Commission or the staff,
acting pursuant to delegated authority, in declaring the Registration Statement
effective as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United States.

[Remainder of page intentionally left blank; signature appears on next page.]

    Very truly yours,

NxSTAGE MEDICAL, INC.

    By:
         /s/ Jeffrey H. Burbank

    Jeffrey H. Burbank

    President and Chief Executive Officer

[Signature Page to Acceleration Request]